These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1926312)

  • 1. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group.
    Petersen LR; Doll LS
    Transfusion; 1991 Oct; 31(8):698-703. PubMed ID: 1926312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. HIV Blood Donor Study Group.
    Petersen LR; Doll LS; White CR; Johnson E; Williams A
    Transfusion; 1993 Jul; 33(7):552-7. PubMed ID: 7687391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group.
    Busch MP; Operskalski EA; Mosley JW; Stevens CE; Schiff ER; Kleinman SH; Lee H; Lee M; Harris M
    Transfusion; 1994 Oct; 34(10):858-64. PubMed ID: 7940656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group.
    Busch MP; Young MJ; Samson SM; Mosley JW; Ward JW; Perkins HA
    Transfusion; 1991 Jan; 31(1):4-11. PubMed ID: 1986462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
    Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG
    N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus.
    Ward JW; Kleinman SH; Douglas DK; Grindon AJ; Holmberg SD
    Transfusion; 1988; 28(4):298-301. PubMed ID: 3388474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural risk factors for acquisition of HIV infection and knowledge about AIDS among male professional blood donors in Delhi.
    Chattopadhya D; Riley LW; Kumari S
    Bull World Health Organ; 1991; 69(3):319-23. PubMed ID: 1893506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository.
    Kleinman SH; Niland JC; Azen SP; Operskalski EA; Barbosa LH; Chernoff AI; Edwards VM; Lenes BA; Marshall GJ; Nemo GJ
    Transfusion; 1989 Sep; 29(7):572-80. PubMed ID: 2672433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologic approaches to surveillance of HIV infection among blood donors.
    Petersen LR; Dodd R; Dondero TJ
    Public Health Rep; 1990; 105(2):153-7. PubMed ID: 2108461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
    de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
    Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.
    Ward JW; Bush TJ; Perkins HA; Lieb LE; Allen JR; Goldfinger D; Samson SM; Pepkowitz SH; Fernando LP; Holland PV
    N Engl J Med; 1989 Oct; 321(14):947-52. PubMed ID: 2779617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.